|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Malvezzi M, Carioli G, Bertuccio P, Rosso T, Boffetta P, Levi F, La Vecchia C and Negri E: European cancer mortality predictions for the year 2016 with focus on leukaemias. Ann Oncol. 27:725–731. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A, Giordano SH, et al: Breast cancer, version 4.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 16:310–320. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Chen W, Sun K, Zheng R, Zheng R, Zeng H, Zhang S, Xia C, Yang Z, Li H, Zou X and He J: Cancer incidence and mortality in China, 2014. Chin J Cancer Res. 30:1–12. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Brueffer C, Vallon-Christersson J, Grabau D, Ehinger A, Häkkinen J, Hegardt C, Malina J, Chen Y, Bendahl PO, Manjer J, et al: Clinical value of RNA sequencing-based classifiers for prediction of the five conventional breast cancer biomarkers: A report from the population-based multicenter Sweden cancerome analysis network-breast initiative. JCO Precision Oncol. 2:1–18. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
O'Regan RM and Nahta R: Targeting forkhead box M1 transcription factor in breast cancer. Biochem Pharmacol. 154:407–413. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Safe S, Abbruzzese J, Abdelrahim M and Hedrick E: Specificity protein transcription factors and cancer: Opportunities for drug development. Cancer Prev Res (Phila). 11:371–382. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Seth A and Watson DK: ETS transcription factors and their emerging roles in human cancer. Eur J Cancer. 41:2462–2478. 2005.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Andrews PG, Kennedy MW, Popadiuk CM and Kao KR: Oncogenic activation of the human Pygopus2 promoter by E74-like factor-1. Mol Cancer Res. 6:259–266. 2008.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lindquist JA and Mertens PR: Cold shock proteins: From cellular mechanisms to pathophysiology and disease. Cell Commun Signal. 16(63)2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Doniger J, Landsman D, Gonda MA and Wistow G: The product of unr, the highly conserved gene upstream of N-ras, contains multiple repeats similar to the cold-shock domain (CSD), a putative DNA-binding motif. New Biol. 4:389–395. 1992.PubMed/NCBI
|
|
12
|
Wurth L, Papasaikas P, Olmeda D, Bley N, Calvo GT, Guerrero S, Cerezo-Wallis D, Martinez-Useros J, García-Fernández M, Hüttelmaier S, et al: UNR/CSDE1 drives a post-transcriptional program to promote melanoma invasion and metastasis. Cancer Cell. 30:694–707. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Arndt S, Unger P, Wacker E, Shimizu T, Heinlin J, Li YF, Thomas HM, Morfill GE, Zimmermann JL, Bosserhoff AK and Karrer S: Cold atmospheric plasma (CAP) changes gene expression of key molecules of the wound healing machinery and improves wound healing in vitro and in vivo. PLoS One. 8(e79325)2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Heidari N, Phanstiel DH, He C, Grubert F, Jahanbani F, Kasowski M, Zhang MQ and Snyder MP: Genome-wide map of regulatory interactions in the human genome. Genome Res. 24:1905–1917. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Pan W, Liang J, Tang H, Fang X, Wang F, Ding Y, Huang H and Zhang H: Differentially expressed microRNA profiles in exosomes from vascular smooth muscle cells associated with coronary artery calcification. Int J Biochem Cell Biol. 118(105645)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang J and Knaut H: Chemokine signaling in development and disease. Development. 141:4199–4205. 2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zlotnik A: Chemokines and cancer. Int J Cancer. 119:2026–2029. 2006.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Strieter RM, Belperio JA, Phillips RJ and Keane MP: CXC chemokines in angiogenesis of cancer. Semin Cancer Biol. 14:195–200. 2004.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Atretkhany KN, Drutskaya MS, Nedospasov SA, Grivennikov SI and Kuprash DV: Chemokines, cytokines and exosomes help tumors to shape inflammatory microenvironment. Pharmacol Ther. 168:98–112. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Garetto S, Sardi C, Morone D and Kallikourdis M: Chemokines and T cell trafficking into tumors: Strategies to enhance recruitment of T cells into tumors. Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy pp 163-177, 2016.
|
|
21
|
Moniuszko A, Czupryna P, Pancewicz S, Rutkowski K, Zajkowska O, Swierzbińska R, Grygorczuk S, Kondrusik M, Owłasiuk P and Zajkowska J: Evaluation of CXCL8, CXCL10, CXCL11, CXCL12 and CXCL13 in serum and cerebrospinal fluid of patients with neuroborreliosis. Immunol Lett. 157:45–50. 2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wang C, Wu K, Yu Q, Zhang S, Gao Z, Liu Y, Ni L, Cheng Y, Guan Z, Shi M, et al: CXCL13, CXCL10 and CXCL8 as potential biomarkers for the diagnosis of neurosyphilis patients. Sci Rep. 6(33569)2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Brysse A, Mestdagt M, Polette M, Luczka E, Hunziker W, Noël A, Birembaut P, Foidart JM and Gilles C: Regulation of CXCL8/IL-8 expression by zonula occludens-1 in human breast cancer cells. Mol Cancer Res. 10:121–132. 2012.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Azenshtein E, Meshel T, Shina S, Barak N, Keydar I and Ben-Baruch A: The angiogenic factors CXCL8 and VEGF in breast cancer: Regulation by an array of pro-malignancy factors. Cancer Lett. 217:73–86. 2005.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Li J, Tang Z, Wang H, Wu W, Zhou F, Ke H, Lu W, Zhang S, Zhang Y, Yang S, et al: CXCL6 promotes non-small cell lung cancer cell survival and metastasis via down-regulation of miR-515-5p. Biomed Pharmacother. 97:1182–1188. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Tian H, Huang P, Zhao Z, Tang W and Xia J: HIF-1α plays a role in the chemotactic migration of hepatocarcinoma cells through the modulation of CXCL6 expression. Cell Physiol Biochem. 34:1536–1546. 2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Ejaeidi AA, Craft BS, Puneky LV, Lewis RE and Cruse JM: Hormone receptor-independent CXCL10 production is associated with the regulation of cellular factors linked to breast cancer progression and metastasis. Exp Mol Pathol. 99:163–172. 2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Mulligan AM, Raitman I, Feeley L, Pinnaduwage D, Nguyen LT, O'Malley FP, Ohashi PS and Andrulis IL: Tumoral lymphocytic infiltration and expression of the chemokine CXCL10 in breast cancers from the Ontario Familial breast cancer registry. Clin Cancer Res. 19:336–346. 2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Bu H, Shu B, Gao F, Liu C, Guan X, Ke C, Cao F, Hinton AO Jr, Xiang H, Yang H, et al: Spinal IFN-γ-induced protein-10 (CXCL10) mediates metastatic breast cancer-induced bone pain by activation of microglia in rat models. Breast Cancer Res Treat. 143:255–263. 2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Datta D, Flaxenburg JA, Laxmanan S, Geehan C, Grimm M, Waaga-Gasser AM, Briscoe DM and Pal S: Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: Relevance for the development of human breast cancer. Cancer Res. 66:9509–9518. 2006.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Fernandez-Pol JA: Increased serum level of RPMPS-1/S27 protein in patients with various types of cancer is useful for the early detection, prevention and therapy. Cancer Genomics Proteomics. 9:203–256. 2012.PubMed/NCBI
|
|
32
|
Zhu Y, Poyurovsky MV, Li Y, Biderman L, Stahl J, Jacq X and Prives C: Ribosomal protein S7 is both a regulator and a substrate of MDM2. Mol Cell. 35:316–326. 2009.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Wang Z, Cotney J and Shadel GS: Human mitochondrial ribosomal protein MRPL12 interacts directly with mitochondrial RNA polymerase to modulate mitochondrial gene expression. J Biol Chem. 282:12610–12618. 2007.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Miller C, Saada A, Shaul N, Shabtai N, Ben-Shalom E, Shaag A, Hershkovitz E and Elpeleg O: Defective mitochondrial translation caused by a ribosomal protein (MRPS16) mutation. Ann Neurol. 56:734–738. 2004.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Yang Y, Cimen H, Han MJ, Shi T, Deng JH, Koc H, Palacios OM, Montier L, Bai Y, Tong Q and Koc EC: NAD+-dependent deacetylase SIRT3 regulates mitochondrial protein synthesis by deacetylation of the ribosomal protein MRPL10. J Biol Chem. 285:7417–7429. 2010.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Yoo YA, Kim MJ, Park JK, Chung YM, Lee JH, Chi SG, Kim JS and Yoo YD: Mitochondrial ribosomal protein L41 suppresses cell growth in association with p53 and p27Kip1. Mol Cell Biol. 25:6603–6616. 2005.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Anchi T, Tamura K, Furihata M, Satake H, Sakoda H, Kawada C, Kamei M, Shimamoto T, Fukuhara H, Fukata S, et al: SNRPE is involved in cell proliferation and progression of high-grade prostate cancer through the regulation of androgen receptor expression. Oncol Lett. 3:264–268. 2012.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Yong WH, Shabihkhani M, Telesca D, Yang S, Tso JL, Menjivar JC, Wei B, Lucey GM, Mareninov S, Chen Z, et al: Ribosomal proteins RPS11 and RPS20, two stress-response markers of glioblastoma stem cells, are novel predictors of poor prognosis in glioblastoma patients. PLoS One. 10(e0141334)2015.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Calvisi DF, Wang C, Ho C, Ladu S, Lee SA, Mattu S, Destefanis G, Delogu S, Zimmermann A, Ericsson J, et al: Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. Gastroenterology. 140:1071–1083. 2011.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Li G, Shan C, Liu L, Zhou T, Zhou J, Hu X, Chen Y, Cui H and Gao N: Tanshinone IIA inhibits HIF-1α and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway. PLoS One. 10(e0117440)2015.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Wang C, Cigliano A, Jiang L, Li X, Fan B, Pilo MG, Liu Y, Gui B, Sini M, Smith JW, et al: 4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras proto-oncogenes in mice. Hepatology. 61:200–213. 2015.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Smeitink J and van den Heuvel L: Human mitochondrial complex I in health and disease. Am J Hum Genet. 64:1505–1510. 1999.PubMed/NCBI View Article : Google Scholar
|
